SecSonar.com

Haleon plc (HLN)

Haleon plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Haleon plc (HLN) is a Drug Manufacturers - Specialty & Generic company based in GB with a market capitalization of $40.5B. Revenue declined 4.0% year-over-year and the company generated $2.6B in free cash flow. This page tracks HLN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 24.56K employees · IPO Jul 25, 2022

Valuation

Valuation & price

$9.26 · as of May 26, 2026 · -17.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$11.27$10.00$8.72Jul 25Dec 25Jul 26Jul 7, 25$10.15Jul 9, 25$10.05Jul 11, 25$9.96Jul 15, 25$9.73Jul 17, 25$9.59Jul 21, 25$9.53Jul 23, 25$9.75Jul 25, 25$9.88Jul 29, 25$9.81Jul 31, 25$9.43Aug 4, 25$9.51Aug 6, 25$9.25Aug 11, 25$9.47Aug 13, 25$9.69Aug 15, 25$9.65Aug 19, 25$9.74Aug 21, 25$9.81Aug 25, 25$9.68Aug 27, 25$9.71Aug 29, 25$9.80Sep 3, 25$9.89Sep 5, 25$9.80Sep 9, 25$9.75Sep 11, 25$9.87Sep 16, 25$9.28Sep 18, 25$9.24Sep 22, 25$9.00Sep 24, 25$8.87Sep 26, 25$8.82Sep 30, 25$8.97Oct 2, 25$8.88Oct 6, 25$8.79Oct 8, 25$9.04Oct 10, 25$9.00Oct 14, 25$9.17Oct 16, 25$9.20Oct 21, 25$9.33Oct 23, 25$9.37Oct 27, 25$9.20Oct 29, 25$9.05Oct 31, 25$9.27Nov 4, 25$9.32Nov 6, 25$9.41Nov 10, 25$9.57Nov 12, 25$9.88Nov 14, 25$9.59Nov 18, 25$9.61Nov 20, 25$9.60Nov 25, 25$9.82Nov 28, 25$9.78Dec 2, 25$9.67Dec 4, 25$9.53Dec 8, 25$9.40Dec 10, 25$9.46Dec 12, 25$9.52Dec 16, 25$9.85Dec 18, 25$9.84Dec 22, 25$9.97Dec 24, 25$10.10Dec 29, 25$10.09Jan 2, 26$10.00Jan 6, 26$10.27Jan 8, 26$10.04Jan 12, 26$9.79Jan 14, 26$9.95Jan 16, 26$9.83Jan 21, 26$10.24Jan 23, 26$10.46Jan 27, 26$10.42Jan 29, 26$10.30Feb 2, 26$10.56Feb 4, 26$10.78Feb 9, 26$10.88Feb 11, 26$11.16Feb 13, 26$11.20Feb 18, 26$11.22Feb 20, 26$11.27Feb 24, 26$11.08Feb 26, 26$10.76Mar 2, 26$10.87Mar 4, 26$10.47Mar 6, 26$10.28Mar 10, 26$10.17Mar 12, 26$10.07Mar 17, 26$10.60Mar 19, 26$10.23Mar 23, 26$9.93Mar 25, 26$9.74Mar 27, 26$9.80Mar 31, 26$10.01Apr 2, 26$9.93Apr 7, 26$9.88Apr 9, 26$10.01Apr 13, 26$9.83Apr 15, 26$9.66Apr 17, 26$9.75Apr 22, 26$9.36Apr 24, 26$9.58Apr 28, 26$9.47Apr 30, 26$9.24May 4, 26$9.24May 6, 26$9.23May 8, 26$9.11May 12, 26$9.10May 14, 26$8.91May 18, 26$9.17May 20, 26$9.28May 22, 26$9.29May 28, 26$9.21Jun 1, 26$8.84Jun 3, 26$8.72Jun 5, 26$9.12Jun 9, 26$9.12Jun 11, 26$9.03Jun 15, 26$9.07Jun 17, 26$8.87Jun 22, 26$8.77Jun 24, 26$9.23Jun 26, 26$9.24Jul 2, 26$9.82
$8.7052-week range$11.27
Loading valuation history…

Fundamentals

Key fundamentals

$40.5B

Market cap

-4.0%

Revenue growth (YoY)

64.8%

Gross margin

$2.6B

Free cash flow (USD)

$7.3B

Net debt

-1.9%

Share dilution

2/6

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$8.5BFY 2020$9.9BFY 2021$9.5BFY 2022$10.9BFY 2023$11.3BFY 2024$11.2BFY 2025$10.8B
$8.5B$10.8B

Free cash flow by year

2019 → 2025

FY 2019$543.0MFY 2020$1.1BFY 2021$1.1BFY 2022$1.7BFY 2023$1.8BFY 2024$2.1BFY 2025$2.0B
$543M$2B

Gross margin by year

2021 → 2025

FY 202162.3%FY 202260.6%FY 202361.6%FY 202461.9%FY 202564.8%
62.3%64.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed Apr 29, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingDirector/PDMR ShareholdingJul 2, 2026Filing
  • 6-K filingTotal Voting Rights and CapitalJul 1, 2026Filing
  • 6-K filingShare Buyback AnnouncementJun 29, 2026Filing
  • 6-K filingShare Buyback AnnouncementJun 22, 2026Filing
  • 6-K filingShare Buyback AnnouncementJun 15, 2026Filing
  • 6-K filingShare Buyback AnnouncementJun 8, 2026Filing
  • 6-K filingShare Buyback AnnouncementJun 1, 2026Filing
  • 6-K filingTotal Voting Rights and CapitalJun 1, 2026Filing
  • 6-K filingShare Buyback AnnouncementMay 26, 2026Filing
  • 6-K filingDirector Shareholding NotificationMay 22, 2026Filing

Questions

Frequently asked questions

What is Haleon plc's market cap?

Haleon plc (HLN) has a market capitalization of $40.5B.

What is HLN's P/E ratio?

A meaningful P/E ratio is not available for HLN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying HLN stock?

SEC Form 4 filings show no open-market insider buys at Haleon plc in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

TEVA

Teva Pharmaceutical Industries Limited

$40.4B

TAK

Takeda Pharmaceutical Company Limited

$50.4B

VTRS

Viatris Inc.

$18.8B

ELAN

Elanco Animal Health Incorporated

$12B

RDY

Dr. Reddy's Laboratories Limited

$11.4B

LNTH

Lantheus Holdings, Inc.

$6.5B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.